1. Home
  2. AMPH vs EEX Comparison

AMPH vs EEX Comparison

Compare AMPH & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • EEX
  • Stock Information
  • Founded
  • AMPH 1996
  • EEX 2013
  • Country
  • AMPH United States
  • EEX United States
  • Employees
  • AMPH N/A
  • EEX N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • EEX Advertising
  • Sector
  • AMPH Health Care
  • EEX Consumer Discretionary
  • Exchange
  • AMPH Nasdaq
  • EEX Nasdaq
  • Market Cap
  • AMPH 1.1B
  • EEX 910.8M
  • IPO Year
  • AMPH 2014
  • EEX 2017
  • Fundamental
  • Price
  • AMPH $21.70
  • EEX $5.18
  • Analyst Decision
  • AMPH Hold
  • EEX Strong Buy
  • Analyst Count
  • AMPH 5
  • EEX 2
  • Target Price
  • AMPH $38.00
  • EEX $7.90
  • AVG Volume (30 Days)
  • AMPH 501.2K
  • EEX 98.3K
  • Earning Date
  • AMPH 08-06-2025
  • EEX 08-06-2025
  • Dividend Yield
  • AMPH N/A
  • EEX 1.13%
  • EPS Growth
  • AMPH N/A
  • EEX N/A
  • EPS
  • AMPH 2.77
  • EEX 0.02
  • Revenue
  • AMPH $730,659,000.00
  • EEX $413,100,000.00
  • Revenue This Year
  • AMPH $0.67
  • EEX $14.85
  • Revenue Next Year
  • AMPH $5.18
  • EEX $6.42
  • P/E Ratio
  • AMPH $7.83
  • EEX $208.46
  • Revenue Growth
  • AMPH 8.05
  • EEX 4.87
  • 52 Week Low
  • AMPH $21.48
  • EEX $3.22
  • 52 Week High
  • AMPH $53.96
  • EEX $6.65
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 28.01
  • EEX 60.46
  • Support Level
  • AMPH $22.81
  • EEX $5.07
  • Resistance Level
  • AMPH $23.77
  • EEX $5.30
  • Average True Range (ATR)
  • AMPH 0.76
  • EEX 0.14
  • MACD
  • AMPH -0.20
  • EEX 0.02
  • Stochastic Oscillator
  • AMPH 9.27
  • EEX 76.92

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.

Share on Social Networks: